11-47437768-G-T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_005055.5(RAPSN):​c.*207C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00841 in 692,626 control chromosomes in the GnomAD database, including 87 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.017 ( 47 hom., cov: 32)
Exomes 𝑓: 0.0059 ( 40 hom. )

Consequence

RAPSN
NM_005055.5 3_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.802

Publications

2 publications found
Variant links:
Genes affected
RAPSN (HGNC:9863): (receptor associated protein of the synapse) This gene encodes a member of a family of proteins that are receptor associated proteins of the synapse. The encoded protein contains a conserved cAMP-dependent protein kinase phosphorylation site, and plays a critical role in clustering and anchoring nicotinic acetylcholine receptors at synaptic sites by linking the receptors to the underlying postsynaptic cytoskeleton, possibly by direct association with actin or spectrin. Mutations in this gene may play a role in postsynaptic congenital myasthenic syndromes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Apr 2011]
RAPSN Gene-Disease associations (from GenCC):
  • fetal akinesia deformation sequence 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • neuromuscular disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics
  • congenital myasthenic syndrome 11
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp
  • fetal akinesia deformation sequence 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 11-47437768-G-T is Benign according to our data. Variant chr11-47437768-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 304966.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0174 (2651/152284) while in subpopulation AFR AF = 0.0486 (2021/41542). AF 95% confidence interval is 0.0469. There are 47 homozygotes in GnomAd4. There are 1296 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 47 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAPSNNM_005055.5 linkc.*207C>A 3_prime_UTR_variant Exon 8 of 8 ENST00000298854.7 NP_005046.2 Q13702-1A0A0S2Z4F8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAPSNENST00000298854.7 linkc.*207C>A 3_prime_UTR_variant Exon 8 of 8 1 NM_005055.5 ENSP00000298854.2 Q13702-1
RAPSNENST00000352508.7 linkc.*207C>A 3_prime_UTR_variant Exon 6 of 6 1 ENSP00000298853.3 Q13702-2
RAPSNENST00000528356.1 linkn.401C>A non_coding_transcript_exon_variant Exon 2 of 2 3
RAPSNENST00000524487.5 linkc.*207C>A 3_prime_UTR_variant Exon 7 of 7 5 ENSP00000435551.2 E9PJP9

Frequencies

GnomAD3 genomes
AF:
0.0174
AC:
2647
AN:
152166
Hom.:
46
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0487
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00510
Gnomad ASJ
AF:
0.00374
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.0151
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00517
Gnomad OTH
AF:
0.0100
GnomAD2 exomes
AF:
0.00621
AC:
692
AN:
111486
AF XY:
0.00521
show subpopulations
Gnomad AFR exome
AF:
0.0486
Gnomad AMR exome
AF:
0.00402
Gnomad ASJ exome
AF:
0.00310
Gnomad EAS exome
AF:
0.000103
Gnomad FIN exome
AF:
0.0140
Gnomad NFE exome
AF:
0.00449
Gnomad OTH exome
AF:
0.00475
GnomAD4 exome
AF:
0.00587
AC:
3173
AN:
540342
Hom.:
40
Cov.:
6
AF XY:
0.00542
AC XY:
1565
AN XY:
288502
show subpopulations
African (AFR)
AF:
0.0442
AC:
647
AN:
14654
American (AMR)
AF:
0.00424
AC:
119
AN:
28058
Ashkenazi Jewish (ASJ)
AF:
0.00348
AC:
61
AN:
17522
East Asian (EAS)
AF:
0.0000324
AC:
1
AN:
30894
South Asian (SAS)
AF:
0.000647
AC:
37
AN:
57210
European-Finnish (FIN)
AF:
0.0120
AC:
367
AN:
30466
Middle Eastern (MID)
AF:
0.00939
AC:
36
AN:
3834
European-Non Finnish (NFE)
AF:
0.00515
AC:
1692
AN:
328470
Other (OTH)
AF:
0.00729
AC:
213
AN:
29234
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
161
323
484
646
807
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0174
AC:
2651
AN:
152284
Hom.:
47
Cov.:
32
AF XY:
0.0174
AC XY:
1296
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0486
AC:
2021
AN:
41542
American (AMR)
AF:
0.00510
AC:
78
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00374
AC:
13
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4832
European-Finnish (FIN)
AF:
0.0151
AC:
160
AN:
10622
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00518
AC:
352
AN:
68016
Other (OTH)
AF:
0.00993
AC:
21
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
128
256
385
513
641
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0146
Hom.:
7
Bravo
AF:
0.0175
Asia WGS
AF:
0.00144
AC:
6
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 19, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Fetal akinesia deformation sequence 1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Congenital myasthenic syndrome 11 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
14
DANN
Benign
0.91
PhyloP100
0.80
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73459751; hg19: chr11-47459319; API